Crinetics (CRNX) PT Lowered to $33 at SVB Leerink, After Clinical Trial Data Released
Tweet
Share
E-mailGet Alerts CRNX Hot Sheet
Price: $84.70 +0.31%
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
SVB Leerink analyst Joseph P. Schwartz lowered the price target on Crinetics (NASDAQ: CRNX) to $33.00 (from $39.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Resona Holdings, Inc (8308:JP) (RSNHF) to Overweight
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
